Haima Therapeutics
startup
Haima Therapeutics is a pre-clinical stage biotechnology company focused on developing bio-inspired therapies for the treatment of bleeding and other blood-related ailments. We have developed a novel, nanoparticle-based synthetic hemostatic technology, called SynthoPlate, that can staunch hemorrhagic bleeding by binding to the site of injury and amplifying your body’s natural clotting mechanisms.
Cleveland, OH, USA
haimatherapeutics.comInaccurate data? Flag it here.Open jobs at Haima Therapeutics